THE ELM GREENWICH
1 EAST PUTNAM AVE (LOWER LEVEL)
GREENWICH, CT 06830
OFFICE HOURS
MON–THU | 8 AM – 4 PM
FRI | 8 AM – 3 PM
CONTACT
T 203-935-8454
F 203-643-2054
E INFO@THEELMGREENWICH.COM
THE ELM WESTPORT
315 MAIN STREET
WESTPORT, CT 06880
OFFICE HOURS
BY APPOINTMENT
CONTACT
T 203-935-8454
E INFO@THEELMGREENWICH.COM

FAQS

We take the time to understand your history, lifestyle, and goals, focusing on root causes rather than masking symptoms. This proactive model promotes long-term wellness, ensuring your care evolves with you and reflects the most current science in women’s health.
The Elm is a boutique concierge gynecology and hormone therapy practice specializing in women’s health, with a strong focus on perimenopause, menopause, and hormone optimization.
Our clinical team includes Dr. Alicia Robbins, who oversees our protocols and board-certified nurse practitioners Katherine Clark and Emilee Bischof, alongside RN Sarah Purcell. Each is trained in The Robbins Method™ to ensure consistent, expert-level care.
Yes. All Elm clinicians are certified by The Menopause Society and bring advanced expertise in midlife women’s health, including bio-identical hormone therapy, testosterone, FDA-approved medications, and longevity treatments.
We do not participate with commercial insurance, as this would limit the time and access we can offer. However:
– Labs, imaging, and pathology (such as pap smears) are billed through your insurance.
– Superbills are provided for annual visits and procedures, which you can submit for potential reimbursement.
Please note: reimbursement is not guaranteed and depends on your individual plan.
Your membership includes medication management and lab ordering, but the cost of medications and labs depends on your insurance coverage. Compounded medications or off-label treatments (such as testosterone or GLP-1 therapies for weight loss) are typically out-of-pocket.
No. Our practitioners are not enrolled in Medicaid or Medicare, so care and prescriptions are managed outside these programs.

Our Virtual Hormone Therapy Program is fully telehealth-based and available to patients in CT, NY, and NJ. It includes secure video visits, messaging access, lab coordination, and prescription management.
Yes. Many of our patients come to us for a second opinion or to transition care. During your initial consultation, we’ll review your current regimen and goals to determine the best next steps.
Most women in perimenopause or menopause experiencing symptoms such as hot flashes, low libido, sleep disruption, brain fog, fatigue, mood changes, or weight gain are strong candidates. The best way to know for certain is to schedule an initial consultation so we can review your health history and goals.
Age alone does not rule you out. Our clinicians will review your cardiovascular and overall health profile to assess safety. Many women benefit from hormone therapy well beyond the “ideal window.”
Book a Complimentary Information Call
Not sure which membership is right for you? We’re here to help.
Every new client at The Elm is invited to begin with a complimentary 15-minute Information Call. This conversation gives you the chance to learn more about our offerings and discover which membership may be the best fit for your care needs.
Who you’ll meet
You’ll speak directly with Karen Retana, Practice Manager at The Elm.
With a background in emergency care and labour & delivery, Karen brings extensive healthcare expertise and a deep dedication to patient experience. She ensures the clinical and operational flow of The Elm is seamless, supporting patients and providers with steady care and precision.
During your call, you will:
- Learn how our memberships work and what they include
- Gain clarity on which option may suit your goals best
- Have the opportunity to ask any questions before joining
SCHEDULE INFO CALL
Important to note:
This call is for informational purposes only. No medical advice will be provided during the conversation.
We currently welcome patients from Connecticut and New York, with plans to expand to New Jersey, Massachusetts, and Arizona in the near future.